Product Information
ALBUTEROL SUL 1.25 MG/3 ML SOL is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $0.2262 per ML under NDC 76204001101. Its NADAC has been published 217 times since Aug 10, 2022.
FDA first approved this application on Dec 28, 2021. Its Orange Book therapeutic-equivalence code is AN.
Strength
1.25 mg/3mL
Manufacturer
Ritedose Pharmaceuticals, LLCNDC
76204001101
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA214531FDA Approved
12/28/2021
TE Code
AN
On Market Since
1/4/2022
Pharmacological Classes
Price Statistics
The NADAC for ALBUTEROL SUL 1.25 MG/3 ML SOL has been published 217 times since Aug 10, 2022, and over the history we have for it it has declined 17.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2262 per ML |
|---|---|
| All-time high | $0.3531 (Apr 12, 2023) |
| All-time low | $0.2198 (Jul 22, 2026) |
| 52-week high | $0.2583 |
| 52-week low | $0.2198 |
| Median price | $0.2621 |
| Average price | $0.2649 |
| Largest weekly change | +16.1% (Jan 17, 2024) |
| Weeks tracked | 217 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ritedose Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Albuterol Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALBUTEROL SUL 1.25 MG/3 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for ALBUTEROL SUL 1.25 MG/3 ML SOL, manufactured by Ritedose Pharmaceuticals, LLC, is $0.2262 per ML (NDC 76204001101), effective Sep 30, 2026.
How has the price of ALBUTEROL SUL 1.25 MG/3 ML SOL changed over time?
Over the history we have for it, the NADAC for ALBUTEROL SUL 1.25 MG/3 ML SOL has declined 17.4%. It has been tracked across 217 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for ALBUTEROL SUL 1.25 MG/3 ML SOL?
Since Aug 10, 2022, the NADAC for ALBUTEROL SUL 1.25 MG/3 ML SOL has ranged from a low of $0.2198 (Jul 22, 2026) to a high of $0.3531 (Apr 12, 2023), with a median of $0.2621 per ML.
Are there cheaper alternatives to ALBUTEROL SUL 1.25 MG/3 ML SOL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALBUTEROL SUL 1.25 MG/3 ML SOL, is $0.1979 per ML — about 13% below ALBUTEROL SUL 1.25 MG/3 ML SOL.
Who manufactures ALBUTEROL SUL 1.25 MG/3 ML SOL?
ALBUTEROL SUL 1.25 MG/3 ML SOL (NDC 76204001101) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.